Gelder Mark S. MD 4
4 · Onconova Therapeutics, Inc. · Filed Sep 29, 2021
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-09-28$4.20/sh+2,381$10,000→ 2,381 total
4 · Onconova Therapeutics, Inc. · Filed Sep 29, 2021
Common Stock